Evidence-Based Treatment and Monitoring Strategies for Dementia-Related Psychosis
Antipsychotics can be used in the short-term to manage dementia-related psychosis, but serious adverse effects can outweigh benefits. Novel antipsychotics or other agents may offer superior efficacy and safety. Explore the evidence in this CME activity.
Category
  • Alzheimer Disease
  • Antipsychotics
  • Dementia
  • Geriatric Psychiatry
  • Neurology
  • Parkinson Disease
  • Psychotic Disorders
Format
  • Self-study / Enduring
Credits
  • AMA PRA Category 1 Credit™
  • Participation
Diagnosis and Pharmacotherapy of Bipolar Depression in Adults
Join Dr Goldberg as he reviews factors that impact the diagnosis of bipolar disorder and current treatments for bipolar depression in adults.
Category
  • Psychopharmacology
  • Side Effects
  • Depression
  • Bipolar Disorder
  • Diagnostic Tools
Format
  • Self-study / Enduring
Credits
  • AMA PRA Category 1 Credit™
  • Participation
Diagnosis and Pharmacotherapy of Bipolar Depression in Pediatric Patients
What are the evidence-based pharmacologic treatment approaches for pediatric patients with bipolar depression?
Category
  • Psychopharmacology
  • Side Effects
  • Child and Adolescent Psychiatry
  • Depression
  • Bipolar Disorder
  • Diagnostic Tools
Format
  • Self-study / Enduring
Credits
  • AMA PRA Category 1 Credit™
  • Participation
Individualizing Treatment Selection for Pediatric and Adult Patients With Bipolar Depression
Drs Findling and Goldberg offer expertise on the diagnosis and treatment of bipolar disorder in patients of all ages.
Category
  • Patient/Physician Communication
  • Mood Disorders
  • Child and Adolescent Psychiatry
  • Depression
  • Bipolar Disorder
  • Antipsychotics
  • Antidepressants
  • Diagnostic Tools
Format
  • Self-study / Enduring
Credits
  • AMA PRA Category 1 Credit™
  • Participation
Tweetorial: Diagnosing and Treating Alzheimer Disease During the Early Stage
Prompt treatment of early-stage Alzheimer disease (AD) can curb symptom progression. Tests for biomarkers, new symptomatic treatments and disease-modifying agents, and the addition of the preclinical stage to AD diagnostic criteria can aid in earlier disease recognition and building treatment plans.
Category
  • Alzheimer Disease
  • Dementia
  • Integrated Care
  • Neuroimaging
  • Patient/Physician Communication
  • Primary Care
Format
  • Self-study / Enduring
Credits
  • AMA PRA Category 1 Credit™
  • Participation
Long COVID in Children and Adolescents
Long COVID symptoms are both physical and mental in nature among children and adolescents and have the potential to affect long-term functioning and increase the overall burden on health care delivery.
Category
  • Child and Adolescent Psychiatry
Format
  • Journal
Credits
  • AMA PRA Category 1 Credit™
  • Participation
Treatment-Resistant Mood Disorders in LGBTQ People: A Retrospective Study of Clinical Features and Response to Electroconvulsive Therapy
In this chart review, LGBTQ people with treatment-resistant mood disorders had clinical features linked to worse outcomes, but their improvement with ECT was similar to that seen in non-LGBTQ patients.
Category
  • Mood Disorders
  • Depression
  • Electroconvulsive Therapy
Format
  • Journal
Credits
  • AMA PRA Category 1 Credit™
  • Participation
Suicide Risk in a National VA Sample: Roles of Psychiatric Diagnosis, Behavior Regulation, Substance Use, and Smoking
Predicting suicide is difficult, as suicidal behavior is not linked solely to any single behavior or psychiatric diagnosis. This study compared risk of suicidal behavior among a transdiagnostic sample of Veterans with varying disorders and behaviors.
Category
  • Bipolar Disorder
  • Schizophrenia/ Schizoaffective Disorders
  • Smoking
  • Substance Use Disorders
  • Suicide
  • Veterans and Military Issues
Format
  • Journal
Credits
  • AMA PRA Category 1 Credit™
  • Participation
Tweetorial: Myasthenia Gravis Disease Mechanisms and the Changing Treatment Landscape
Patients with generalized myasthenia gravis (gMG) receive multiple immunosuppressive therapies, but with incomplete suppression of IgG autoantibodies. Read this rapid update in gMG to learn about novel therapies that can more effectively suppress IgG autoantibodies through a novel mechanism of action to help your patients achieve better clinical outcomes.
Category
  • Myasthenia Gravis
Format
  • Self-study / Enduring
Credits
  • AMA PRA Category 1 Credit™
  • Participation
Facilitating Treatment Initiation in Early-Stage Alzheimer Disease
Many new therapies for early-stage AD have made their way onto the scene that can delay onset of the disease and/or slow down progression. Find out the how, what, when to better treat your patients with AD from specialists in the field.
Category
  • Primary Care
  • Patient/Physician Communication
  • Neuroimaging
  • Alzheimer Disease
  • Dementia
  • Integrated Care
Format
  • Video
Credits
  • AMA PRA Category 1 Credit™
  • Participation

Pages